-
Exscientia announces EUR250 Million collaboration
pharmassia
May 25, 2017
Exscientia collaborates for a Multiple-Product Development and Licence Option Agreement with Sanofi.
-
Takeda and GammaDelta Therapeutics announces collaboration
pharmaasia
May 25, 2017
Takeda Pharmaceutical Company Limited and GammaDelta Therapeutics Ltd, an Abingworth portfolio company, announced that they have formed a strategic collaboration to develop GammaDelta Therapeutics’ novel T cell platform...
-
Beactica Announces Glioblastoma Research Collaboration with Uppsala University and the DDD Platform
b3cnewswire
May 17, 2017
Beactica AB announced a new research collaboration with Uppsala University and the Drug Discovery and Development Platform at SciLifeLab to study the effects on brain cancer stem cells of specific small molecules under development by Beactica.
-
BMS, Calithera Biosciences Expand Clinical Collaboration
contractpharma
May 11, 2017
Will evaluate Opdivo in combination with CB-839 in NSCLC and Melanoma
-
Exscientia signs collaboration deal with Sanofi for multiple product development
pharmaceutical-technology
May 11, 2017
Artificial Intelligence-driven drug discovery firm Exscientia has formed a strategic research collaboration with Sanofi by signing a licence option agreement in the high-interest area of metabolic disease.
-
Crown Bioscience Enters Antibody Collaboration
contractpharma
May 10, 2017
Crown Bioscience will collaborate to develop a cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibody with Jiangsu Qyun Bio-Pharmaceutical.
-
Novartis and Amgen expand global collaboration to commercialise AMG 334
pharmaceutical-technology
April 27, 2017
Novartis has entered an expanded commercialisation agreement with Amgen for AMG 334 (erenumab), which is being...
-
Servier and CTI BioPharma Expand Pixuvri Agreement
americanpharmaceuticalreview
April 27, 2017
Servier and CTI BioPharma announced that they agreed to expand their existing license and development collaboration agreement for Pixuvri.
-
HITGEN announces drug discovery collaboration with The Scripps Research Institute and the California
en-cphi.cn
April 24, 2017
HitGen Ltd. announced today a collaboration with The Scripps Research Institute (TSRI) and its affiliate, the California Institute for Biomedical Research (Calibr).
-
Lhasa and Optibrium enter research and product development collaboration
pharmaasia
April 24, 2017
Drug discovery software specialists combine expertise to extend studies into drug metabolism modelling